Official Title
The Role of Honey and Nigella Sativa in the Management of COVID-19; A Randomized Controlled, Open-label, Add-on Trial in Pakistan
Brief Summary

To evaluate the effectiveness of Nigella Sativa and honey stirred in 250 ml of distilled water 12 hourly till patient becomes asymptomatic or a maximum of 14 days with standard hospital care versus standard hospital care alone with placebo capsule and 250 ml water, in clearing the COVID-19 nucleic acid from throat and nasal swab, lowering disease detrimental effects on HRCT chest/X-ray and severity of symptoms along with duration of hospital stay till day 14th day of follow up and 30 days mortality (primary outcomes).

Detailed Description

This cohort, adaptive, randomized, double armed group, controlled, Investigator Initiated
interventional study is designed to demonstrate the superiority of a combination of black
cumin with honey over standard care in SARS-CoV-2 (COVID-19) infected patients who consent to
randomization following a new diagnosis in Pakistan with an SSC-2 score of > 5 with positive
RT-PCR of COVID-19.

Completed
Coronavirus Infection
SARS-COV2

Drug: Honey

1gm/Kg/Day

Drug: Nigella Sativa / Black Cumin

80mg/Kg/day

Drug: Placebos

Empty capsule with 250ml of distilled water

Eligibility Criteria

Inclusion Criteria:

- Confirmed SARS-CoV-2 (COVID-19) infection by a positive test result with SSC-2 score>
5

- Patients admitted in Corona centers

Exclusion Criteria:

- Participants not giving consent.

- Pregnant and lactating females.

- History of allergy to any drug being administered in this study

- Severely terminally ill patients

- Patients on Nil Per Oral

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Pakistan
Locations

Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital
Lahore, Punjab, Pakistan

Services Institute of Medical Sciences, Services Hospital
Lahore, Punjab, Pakistan

Sohaib Ashraf
NCT Number
Keywords
SARS-CoV-2
Covid-19
Coronavirus
Honey
Nigella Sativa
Black Cummin
Herbal Medicine
MeSH Terms
COVID-19
Coronavirus Infections